ATE468127T1 - Ii-key/antigene epitop-hybrid-peptid-vakzine - Google Patents

Ii-key/antigene epitop-hybrid-peptid-vakzine

Info

Publication number
ATE468127T1
ATE468127T1 AT03789700T AT03789700T ATE468127T1 AT E468127 T1 ATE468127 T1 AT E468127T1 AT 03789700 T AT03789700 T AT 03789700T AT 03789700 T AT03789700 T AT 03789700T AT E468127 T1 ATE468127 T1 AT E468127T1
Authority
AT
Austria
Prior art keywords
mhc class
terminal
interest
nucleic acid
polypeptide
Prior art date
Application number
AT03789700T
Other languages
English (en)
Inventor
Robert Humphreys
Minzhen Xu
Original Assignee
Antigen Express Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/245,871 external-priority patent/US20030235594A1/en
Application filed by Antigen Express Inc filed Critical Antigen Express Inc
Priority claimed from PCT/US2003/028574 external-priority patent/WO2004030616A2/en
Application granted granted Critical
Publication of ATE468127T1 publication Critical patent/ATE468127T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03789700T 2002-09-17 2003-09-12 Ii-key/antigene epitop-hybrid-peptid-vakzine ATE468127T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/245,871 US20030235594A1 (en) 1999-09-14 2002-09-17 Ii-Key/antigenic epitope hybrid peptide vaccines
US10/253,286 US7179645B2 (en) 2002-09-24 2002-09-24 Ii-Key/antigenic epitope hybrid peptide vaccines
PCT/US2003/028574 WO2004030616A2 (en) 2002-09-17 2003-09-12 Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES

Publications (1)

Publication Number Publication Date
ATE468127T1 true ATE468127T1 (de) 2010-06-15

Family

ID=31993142

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03789700T ATE468127T1 (de) 2002-09-17 2003-09-12 Ii-key/antigene epitop-hybrid-peptid-vakzine

Country Status (3)

Country Link
US (2) US7179645B2 (de)
AT (1) ATE468127T1 (de)
DE (1) DE60332645D1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9289487B2 (en) * 1999-09-14 2016-03-22 Antigen Express, Inc. II-key/antigenic epitope hybrid peptide vaccines
US7601351B1 (en) 2002-06-26 2009-10-13 Human Genome Sciences, Inc. Antibodies against protective antigen
WO2006098769A2 (en) * 2004-09-24 2006-09-21 Afg Biosolutions, Inc. Multipathogen and monopathogen protection against the bacterial and viral infections associated with biological warfare, cardiac diseases, and cancers
JP5116150B2 (ja) * 2005-09-07 2013-01-09 日本電気株式会社 Ｈｌａ結合性ペプチド、それをコードするｄｎａ断片および組み換えベクター
CA2622036A1 (en) * 2005-09-08 2007-03-15 Henry M. Jackson Foundation For The Advancement Of Military Medicine, In C. Targeted identification of immunogenic peptides
US8945573B2 (en) * 2005-09-08 2015-02-03 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Targeted identification of immunogenic peptides
CA2523032A1 (en) * 2005-10-07 2007-04-07 Immunovaccine Technologies Inc. Vaccines for cancer therapy
EP1957528B1 (de) * 2005-11-30 2012-11-07 University of Copenhagen Nucleotid-vakzine
US9202184B2 (en) * 2006-09-07 2015-12-01 International Business Machines Corporation Optimizing the selection, verification, and deployment of expert resources in a time of chaos
US7809660B2 (en) * 2006-10-03 2010-10-05 International Business Machines Corporation System and method to optimize control cohorts using clustering algorithms
US20080294459A1 (en) * 2006-10-03 2008-11-27 International Business Machines Corporation Health Care Derivatives as a Result of Real Time Patient Analytics
US8145582B2 (en) * 2006-10-03 2012-03-27 International Business Machines Corporation Synthetic events for real time patient analysis
US8055603B2 (en) * 2006-10-03 2011-11-08 International Business Machines Corporation Automatic generation of new rules for processing synthetic events using computer-based learning processes
EP2629094A1 (de) 2007-01-24 2013-08-21 Carnegie Mellon University Optische Biosensoren
US7788203B2 (en) * 2007-02-26 2010-08-31 International Business Machines Corporation System and method of accident investigation for complex situations involving numerous known and unknown factors along with their probabilistic weightings
US7970759B2 (en) 2007-02-26 2011-06-28 International Business Machines Corporation System and method for deriving a hierarchical event based database optimized for pharmaceutical analysis
US7853611B2 (en) * 2007-02-26 2010-12-14 International Business Machines Corporation System and method for deriving a hierarchical event based database having action triggers based on inferred probabilities
US7792774B2 (en) 2007-02-26 2010-09-07 International Business Machines Corporation System and method for deriving a hierarchical event based database optimized for analysis of chaotic events
US20080294361A1 (en) * 2007-05-24 2008-11-27 Popp Shane M Intelligent execution system for the monitoring and execution of vaccine manufacturing
JP5731198B2 (ja) 2007-09-27 2015-06-10 イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． インビボでのポリヌクレオチドの送達のための連続疎水相を含む担体におけるリポソームの使用
US7930262B2 (en) * 2007-10-18 2011-04-19 International Business Machines Corporation System and method for the longitudinal analysis of education outcomes using cohort life cycles, cluster analytics-based cohort analysis, and probabilistic data schemas
WO2009079212A2 (en) * 2007-12-03 2009-06-25 Carnegie Mellon University Linked peptide fluorogenic biosensors
US7779051B2 (en) * 2008-01-02 2010-08-17 International Business Machines Corporation System and method for optimizing federated and ETL'd databases with considerations of specialized data structures within an environment having multidimensional constraints
US9605035B2 (en) * 2008-01-10 2017-03-28 Research Development Foundation Vaccines and diagnostics for the ehrlichioses
CN102056622B (zh) 2008-06-05 2016-04-06 免疫疫苗技术有限公司 包含脂质体、抗原、多核苷酸和含疏水物质的连续相的载体的组合物
WO2010027973A1 (en) 2008-09-02 2010-03-11 Antigen Express, Inc. Human papillomavirus / li-key hybrids and methods of use
AU2009317691A1 (en) * 2008-11-21 2010-05-27 Kobenhavns Universitet (University Of Copenhagen) Priming of an immune response
CA2750922A1 (en) * 2009-01-28 2010-08-05 Antigen Express, Inc. Li-key hybrid peptides that modulate the immune response to influenza
US8187611B2 (en) * 2009-10-29 2012-05-29 Albert Einstein College Of Medicine Of Yeshiva University Anti-peptide antibodies that cross react with protective antigen of Bacillus anthracis and uses thereof
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
US10318877B2 (en) 2010-10-19 2019-06-11 International Business Machines Corporation Cohort-based prediction of a future event
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
EP2568289A3 (de) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
ES2741649T3 (es) * 2011-10-28 2020-02-11 Regeneron Pharma Ratones con complejo mayor de histocompatibilidad modificado genéticamente
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
JP6608282B2 (ja) 2012-10-30 2019-11-20 アラヴァックス ピーティーワイ リミテッド 新規免疫療法用分子およびその使用
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
RU2689552C2 (ru) 2013-09-25 2019-05-28 Аравакс Пти Лтд Новая иммунотерапевтическая композиция и ее применения
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
CN105753989A (zh) * 2014-12-15 2016-07-13 牛津疫苗医学生物科技（英国）有限公司 人工多抗原融合蛋白及其制备和应用
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US11505581B2 (en) * 2015-05-14 2022-11-22 La Jolla Institute For Allergy And Immunology Antigens and T cell epitopes from cockroach and methods of making and using same
GB201704417D0 (en) 2017-03-20 2017-05-03 Univ Copenhagen Improved li vaccine adjuvant
CN114010777B (zh) * 2021-08-31 2022-07-22 王树毅 一种多佐剂制备多组分疫苗的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
DE3586772T2 (de) 1984-07-24 1993-03-04 Coselco Mimotopes Pty Ltd Verfahren zur bestimmung von mimotopen.
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US6133029A (en) 1988-03-21 2000-10-17 Chiron Corporation Replication defective viral vectors for infecting human cells
US5194425A (en) 1988-06-23 1993-03-16 Anergen, Inc. Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
DE69020143T2 (de) 1989-02-17 1996-01-25 Chiron Mimotopes Pty Ltd Verfahren zur verwendung und herstellung von peptiden.
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5126132A (en) 1989-08-21 1992-06-30 The United States Of America As Represented By The Department Of Health And Human Services Tumor infiltrating lymphocytes as a treatment modality for human cancer
EP0897987B1 (de) 1989-10-24 2001-02-28 Chiron Corporation Sekretion vom mit Gamma-Interferon Signalpeptid gebundenen humänen Protein
US6120769A (en) 1989-11-03 2000-09-19 Immulogic Pharmaceutical Corporation Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
US5747334A (en) 1990-02-15 1998-05-05 The University Of North Carolina At Chapel Hill Random peptide library
EP0558671B1 (de) 1990-11-21 1999-01-27 Iterex Pharmaceuticals Ltd. Partnership Synthese äquimolarer mischungen vielzähliger oligomere, speziell oligopeptidmischungen
US6419931B1 (en) * 1991-08-26 2002-07-16 Epimmune Inc. Compositions and methods for eliciting CTL immunity
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
AU671971B2 (en) 1991-11-29 1996-09-19 Chiron Corporation Anti-cancer immunotherapeutic vector constructs
US5679527A (en) 1992-03-25 1997-10-21 Antigen Express, Inc. Modification of polypeptide structure
CA2142007C (en) * 1992-08-11 2007-10-30 Robert Glen Urban Immunomodulatory peptides
AU5670194A (en) 1992-11-20 1994-06-22 Enzon, Inc. Linker for linked fusion polypeptides
US5559028A (en) 1993-05-19 1996-09-24 Antigen Express, Inc. Methods of enhancing or antigen presentation to T cells inhibiting
US5874214A (en) 1995-04-25 1999-02-23 Irori Remotely programmable matrices with memories
EP0800545B2 (de) 1995-11-01 2011-03-02 Bracco Research S.A. Gezielte magnetisch markierte molekularmarkersysteme als nmr-bilderzeugungsmittel
AU3307497A (en) 1996-06-26 1998-01-14 Antigen Express, Inc. Immunotherapy by modulation of antigen presentation
US6432409B1 (en) * 1999-09-14 2002-08-13 Antigen Express, Inc. Hybrid peptides modulate the immune response

Also Published As

Publication number Publication date
US20040058881A1 (en) 2004-03-25
US20080305122A1 (en) 2008-12-11
DE60332645D1 (de) 2010-07-01
US7179645B2 (en) 2007-02-20

Similar Documents

Publication Publication Date Title
DE60332645D1 (de) Ii-key/antigene epitop-hybrid-peptid-vakzine
GB2439474A (en) LI-Key/Antigenic epitope hybrid peptide vaccines
CA2289912A1 (en) Human receptor proteins; related reagents and methods
NO995002D0 (no) Modifiserte TNF-<alfa>-molekyler, DNA som koder for slike modifiserte TNF-<alfa>-molekyler og vaksiner omfattende slike TNF-<alfa>-molekyler og DNA
NZ333999A (en) GnRH-leukotoxin chimeric proteins for use in vaccines
ATE366313T1 (de) Antigene peptide aus neisseria
ATE298798T1 (de) Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin
ATE378590T1 (de) Verfahren zum auffinden von peptiden zur verwendung in der immuntherapie
SE9402089D0 (sv) Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
Waxman et al. Primary structure of the COOH-terminal membranous segment of a penicillin-sensitive enzyme purified from two Bacilli.
JPS6470498A (en) Synthetic peptide and antibody thereto
ATE327251T1 (de) Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen
CA2542104A1 (en) Method for the identification of epitopes related to immunogenicity in biopharmaceuticals
Krikorian et al. A peptide carrier with a built-in vaccine adjuvant: construction of immunogenic conjugates
Horváth et al. Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage
JP2025504871A5 (de)
WO2023038961A3 (en) Common cold coronavirus t cell epitopes, methods and uses thereof
JP2025503079A5 (de)
ATE357526T1 (de) Modifizierte hcv peptid-impfstoffe
NO20005081L (no) Et polypeptid som omfatter aminosyren fra et N-terminalt kolinbindende protein A trunkat, vaksine avledet derav og anvendelser derav
Chong et al. Comparative immunological properties of enantiomeric peptides
Patel et al. A cyclic peptide analogue of the loop III region of platelet‐derived growth factor‐BB is a synthetic antigen for the native protein
PE20010239A1 (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos
Verdoliva et al. Antigenicity of topochemically related peptides
WO2004056316A8 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties